Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Filatova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), I. Vasilyev? (Moscow, Russian Federation), V. Testov (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), I. Medvinskiy (Moscow, Russian Federation), A. Senin (Moscow, Russian Federation). Timing of relapse of tuberculosis in people with co-infection (HIV/TB). 492

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020 Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017 The twin epidemics: HIV / DR-TB co-infection in 2012 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Hospitalized tuberculosis: HIV versus non-HIV patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Recurrent tuberculosis among HIV infected persons in Singapore Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Source: Eur Respir J 2016; 48: 1420-1428 Year: 2016 Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 On tuberculosis and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020 Year: 2020 Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Impact of seasons on tuberculosis mortality for HIV+ and HIV- TB patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Multidrug-resistant TB in children with HIV infection Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Predictors of death in patients with MDR-TB and HIV Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020